Biodegradable polyoxalate and copolyoxalate particles for drug-delivery applications

Therapeutic Delivery

Volumn 2, Issue 11, 2011, Pages 1407-1417

  Hong, Donghyun ^a   Song, Byungjoo ^a   Kim, Hyungmin ^a   Kwon, Jungil ^a   Khang, Gilson ^a   Lee, Dongwon ^a  

^a Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOMATERIAL; CATALASE; COPOLYMER; DRUG CARRIER; HYDROXYBENZYL ALCOHOL; NANOPARTICLE; OXALIC ACID; POLYCAPROLACTONE; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BIODEGRADABILITY; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; CYTOSOLIC FRACTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; ENDOSOME; HEADACHE; HUMAN; HYDROPHOBICITY; INFLAMMATORY DISEASE; MACROPHAGE ACTIVATION; MICROENCAPSULATION; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; TETANUS;

EID: 80054911251     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.113     Document Type: Review

References (61)

1. Seong K, Seo S, Ahn W et al. Enhanced cytosolic drug delivery using fully biodegradable poly(amino oxalate) particles. J. Control. Release 152(2), 257-263 (2011).
2. Lee E, Kim S, Seong K et al. A biodegradable and biocompatible drug-delivery system based on polyoxalate microparticles. J. Biomater. Sci. Polym. Ed. 22 (13), 1683-1694 (2011).
3. Paramonov SE, Bachelder EM, Beaudette TT et al. Fully acid-degradable biocompatible polyacetal microparticles for drug delivery. Bioconjug. Chem. 19(4), 911-919 (2008).
4. Haag R, Kratz F. Polymer therapeutics: concepts and applications. Angew. Chem. Int. Ed. Engl. 45(8), 1198-1215 (2006).
5. Kim BS, Oh JM, Kim KS et al. BSA-FITC-loaded microcapsules for in vivo delivery. Biomaterials 30(5), 902-909 (2009).
6. Kim S, Park H, Song Y et al. Reduction of oxidative stress by p-hydroxybenzyl alcohol-containing biodegradable polyoxalate nanoparticulate antioxidant. Biomaterials 32(11), 3021-3029 (2011).
7. Soo PL, Dunne M, Liu J et al. Nano-sized advanced delivery systems as parenteral formulaiton strategies for hydrophobic anti-cancer drugs. In: Nanotechnology in Drug Delivery. de Villiers M, Aramwit P Kwon G (Eds). Springer, NY, USA 349-383 (2009).
8. Lamprecht A, Ubrich N, Yamamoto H et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 299(2), 775-781 (2001).
9. Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 45(3), 285-294 (1998).
10. Cai C, Bakowsky U, Rytting E et al. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein. Eur. J. Pharm. Biopharm. 69(1), 31-42 (2008).
11. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 303(5665), 1818-1822 (2004).
12. Farokhzad OC, Cheng JJ, Teply BA et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl Acad. Sci. USA 103(16), 6315-6320 (2006).
13. Betancourt T, Dorion A, Homan K et al. Controlled release and nanotechnology. In: Nanotechnology in Drug Delivery. de Villiers M, Aramwit P, Kwon G (Eds). Springer, NY, USA 283-312 (2009).
14. Huang X,Brazel CS On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Release 73(2-3), 121-136 (2001).
15. Grayson ACR, Voskerician G, Lynn A et al. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J. Biomater. Sci. Polym. Ed. 15(10), 1281-1304 (2004).
16. Heffernan MJ, Kasturi SP, Yang SC et al. The stimulation of CD8(+) T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid). Biomaterials 30(5), 910-918 (2009).
17. Erdmann L, Uhrich KE. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters). Biomaterials 21(19), 1941-1946 (2000).
18. Kim MS, Seo KS, Khang G et al. Preparation of poly(ethylene glycol)-block-poly(caprolactone) copolymers and their applications as thermo-sensitive materials. J. Biomed. Mater. Res. A 70(1), 154-158 (2004).
19. Coccoli V, Luciani A, Orsi S et al. Engineering of poly(epsilon- caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J. Mater. Sci. Mater. Med. 19(4), 1703-1711 (2008).
20. Gopferich A, Tessmar J. Polyanhydride degradation and erosion. Adv. Drug Deliv. Rev. 54(7), 911-931 (2002).
21. Heller J, Barr J, Ng SY et al. Poly(ortho esters): synthesis, characterization, properties and uses. Adv. Drug Deliv. Rev. 54(7), 1015-1039 (2002).
22. Yang J, Lee CH, Park J et al. Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer. J. Mater. Chem. 17(26), 2695-2705 (2007).
23. Zhang N, Chittasupho C, Duangrat C et al. PLGA nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjug. Chem. 19(1), 145-152 (2008).
24. Yoo JY, Kim JM, Seo KS et al. Characterization of degradation behavior for PLGA in various pH condition by simple liquid chromatography method. Biomed. Mater. Eng. 15(4), 279-288 (2005).
25. Panyam J, Zhou WZ, Prabha S et al. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 16(10) (2002).
26. Murakami H, Kobayashi M, Takeuchi H et al. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm. 187(2), 143-152 (1999).
27. Yang SC, Bhide M, Crispe IN et al. Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. Bioconjug. Chem. 19(6), 1164-1169 (2008).
28. Lee S, Yang SC, Heffernan MJ et al. Polyketal microparticles: a new delivery vehicle for superoxide dismutase. Bioconjug. Chem. 18(1), 4-7 (2007).
29. Heffernan MJ, Murthy N. Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. Bioconjug. Chem. 16(6), 1340-1342 (2005).
30. Sy JC, Seshadri G, Yang SC et al. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat. Mater. 7(11), 863-869 (2008).
31. Park H, Kim S, Song Y et al. Antioxidant and anti-inflammatory activities of hydroxybenzyl alcohol releasing biodegradable polyoxalate nanoparticles. Biomacromolecules 11(8), 2103-2108 (2010).
32. Khaja SD, Lee S, Murthy N. Acid-degradable protein delivery vehicles based on metathesis chemistry. Biomacromolecules 8(5), 1391-1395 (2007).
33. Johnson RA, Shalaby SW. Effect of structure on properties of absorbable oxalate polymers. In: Polymers of Biological and Biomedical Significance. Shalaby SW, Ikada Y, Langer R. Williams J (Eds). American Chemical Society, Washington, DC, USA (1993).
34. Holland SJ, Tighe BJ, Gould PL Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. J. Control. Release 4(3), 155-180 (1986).
35. Kim S, Seong K, Kim O et al. Polyoxalate nanoparticles as a biodegradable and biocompatible drug delivery vehicle. Biomacromolecules 11(3), 555-560 (2010).
36. Kim S, Yoo H, Khang G et al. Synthesis and characterization of high molecular weight biodegradable polyoxalate. Polymer Korea 34(6), 547-552 (2010).
37. Lee D, Khaja S, Velasquez-Castano JC et al. In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nat. Mater. 6, 765-769 (2007).
38. Lee I, Hwang O, Yoo D et al. Detection of hydrogen peroxide in vitro and in vivo using peroxalate chemiluminescence micelles. Bull. Korean Chem. Soc. 32(7), 1-6 (2011).
39. Shen H, Ackerman AL, Cody V et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117(1), 78-88 (2006).
40. Hu Y, Litwin T, Nagaraja AR et al. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett. 7(10), 3056-3064 (2007).
41. Vasir JK, Labhasetwar V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 29(31), 4244-4252 (2008).
42. Lee Y, Ishii T, Cabral H et al. Charge-conversional polyionic complex micelles-efficient nanocarriers for protein delivery into cytoplasm. Angew. Chem. Int. Ed. Engl. 48(29), 5309-5312 (2009).
43. Jones RA, Cheung CY, Black FE et al. Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. Biochem. J. 372(1), 65-75 (2003).
44. Mastrobattista E, Koning GA, van Bloois L et al. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J. Biol. Chem. 277(30), 27135-27143 (2002).
45. Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv. Drug Deliv. Rev. 59(8), 718-728 (2007).
46. Zhang J, Lei Y, Dhaliwal A et al. Protein-polymer nanoparticles for nonviral gene delivery. Biomacromolecules 12(4), 1006-1014 (2011).
47. Foster S, Duvall CL, Crownover EF et al. Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy. Bioconjug. Chem. 21(12), 2205-2212 (2010).
48. Zhao MX, Biswas A, Hu BL et al. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials 32(22), 5223-5230 (2011).
49. Coue G, Engbersen JFJ. Functionalized linear poly(amidoamine)s are efficient vectors for intracellular protein delivery. J. Control. Release 152(1), 90-98 (2011).
50. Shu SJ, Zhang XG, Wu ZM et al. Gradient cross-linked biodegradable polyelectrolyte nanocapsules for intracellular protein drug delivery. Biomaterials 31(23), 6039-6049 (2010).
51. Patil ML, Zhang M, Taratula O et al. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternizationand cancer targeting. Biomacromolecules 10(2), 258-266 (2009).
52. Febvay S, Marini DM, Belcher AM et al. Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption. Nano Letters 10(6), 2211-2219 (2010).
53. Flanary S, Hoffman AS, Stayton PS. Antigen Delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation. Bioconjug. Chem. 20(2), 241-248 (2009).
54. Cho YW, Kim JD, Park K. Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol. 55(6), 721-734 (2003).
55. Jin T, Zhu HH, Wu F et al. Preparing polymer-based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents. J. Control. Release 128(1), 50-59 (2008).
56. Prudencio A, Schmeltzer RC, Uhrich KE. Effect of linker structure on salicylic acid-derived poly(anhydride-esters). Macromolecules 38(16), 6895-6901 (2005).
57. Harten RD, Svach DJ, Schmeltzer R et al. Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo. J. Biomed. Mater. Res. A 72(4), 354-362 (2005).
58. Yu SJ, Kim JR, Lee CK et al. Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions. Biol. Pharm. Bull. 28(6), 1016-1020 (2005).
59. Kim HJ, Hwang IK, Won MH. Vanillin, 4-hydroxybenzyl aldehyde and 4-hydroxybenzyl alcohol prevent hippocampal CA1 cell death following global ischemia. Brain Res. 1181, 130-141 (2007).
60. Liu JK, Mori A. Antioxidant and prooxidant activities of p-hydroxybenzyl alcohol and vanilline-effects on free radicals, brain peroxidation and degradation of benzoate, deoxyribose, amino-acids and DNA. Neuropharmacology 32(7), 659-669 (1993).
61. Jang YW, Lee JY, Kim CJ. Anti-asthmatic activity of phenolic compounds from the roots of Gastrodia elata Bl. Int. Immunopharmacol. 10(2), 147-154 (2010).